RNA-Seq for High Throughput Clinical Studies Wenzhong Xiao, Assistant Professor of Bioinformatics, Massachusetts General Hospital, speaking at Next-Gen Sequencing Congress 2011.
Preclinical Drug Safety: High Quality Data obtained with a New Automated Patch Clamp Platform Olaf Scheel, CSO, Cytocentrics AG speaking at Pharma Outsourcing Congress 2011
Discovery Chemistry Outsourcing: Optimising the Process Luigi LaVecchia, Director, Global Discovery Chemistry, Novartis speaking at Pharma Outsourcing Congress 2011
In a Virtual World, Where Are the Walls of the House? The New Outsourcing Katya Tsaioun, President, Apredica speaking at Pharma Outsourcing Congress 2011
Clinical Trials Utilising Radioactivity in Support of Drug Development Stephen Madden, Head, Metabolism and Pharmacokinetics, Charles River speaking at ADMET Europe 2011
Selecting the right CMO partner David Downey, VP, Commercial Operations, Almac Group speaking at Pharma Outsourcing Congress 2011
How to Obtain a Solid Track Record in Medicinal Chemistry Research Services Bruno Giethlen, Chief Scientific Officer, Prestwick Chemicals speaking at Pharma Outsourcing Congress 2011
Biomarkers of Metabolic Syndrome in Clinical Trials This will discuss the latest developments in biomarkers for metabolic syndrome. The topics will include: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) dysfunctional HDL biomarkers in metabolic syndrome, and 3) kidney injury markers and their usefulness in diabetic nephropathy.
Smarter Regulation: the Key to Radical Transformation of the Pharmaceutical Industry Joyce Tait, Professor, University of Edinburgh, speaking at the Pharma Outsourcing Congress 2010.